Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

Doctors receiving drugmaker payments more likely to prescribe their products, BMJ study finds

August 22, 2016 Research and Development, Sales and Marketing

US physicians who received gifts and other payments from drug companies were more likely to prescribe branded anticoagulants and diabetes …
News
sanofi_multaq

FDA delays appraisal of Sanofi, Zealand diabetes drug just days before decision due

August 22, 2016 Research and Development, Sales and Marketing NDA, Sanofi, appraisal, diabetes, iglarlixi, type 2, type-2, zealand

There was unfortunate news for Sanofi and Zealand Pharma as the FDA announced that it required additional information, constituting a …
News
clinical_trial_3

Intercept’s Ocaliva meets primary endpoint in Phase III trial for rare liver disease

August 18, 2016 Medical Communications, Research and Development intercept, ocaliva

Intercept Pharmaceuticals have announced the publication of Phase III results published in the New England Journal of Medicine, where Ocaliva …
News
shutterstock_512649

Chinese investors plan $1 billion US biotech site

August 18, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

China’s state-backed developer Greenland Holdings is set to jointly invested over $1 billion in a San Francisco-based biotech industrial park …
News
remicade_packshot

J&J loses Remicade patent fight, pledges to continue fight against biosimilars

August 18, 2016 Research and Development, Sales and Marketing Johnson and Johnson, Remicade, biosimilar, biosimilars, infliximab, patent

Johnson and Johnson has announced that it has lost in a patent dispute between biosimilar makers Celltrion and Hospira, relating …
News

Pfizer’s Xalkori price drop secures NICE recommendation

August 18, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NICE, Pfizer, Xalkori, crizotinib, lung cancer

The National Institute for Health and Care Excellence (NICE) has recommended Pfizer’s Xalkori (crizotinib) as a treatment for lung cancer, …
News
merck_incweb

MSD joins Medivation race, says reports

August 18, 2016 Manufacturing and Production, Research and Development, Sales and Marketing MSD, Medivation, Merck, Pfizer, Sanofi, Xtandi, takeover

MSD, known as Merck in the US and Canada, is said to have declared its interest in buying US oncology …
News

NICE says Afinitor and Imbruvica “may be removed” from Cancer Drugs Fund

August 18, 2016 Research and Development, Sales and Marketing Afinitor, Cancer Drugs Fund, Janssen, NICE, Novartis, imbruvica

NICE has published draft guidance advising the removal of Novartis’s Afinitor (everolimus) and Janssen’s Imbruvica (ibrutinib) from the Cancer Drugs …
News
chemo-web

Untested cancer drug suspected cause of three deaths at German alternative medicine centre

August 17, 2016 Research and Development 3-Bromopyruvate, Cancer, Germany, alternative medicine, patient deaths

The deaths of three patients at an alternative medicine clinic in Germany have prompted suspicion of a clinically untested cancer …
News
shutterstock_141299494

GSK, Roche and Novo back $86 million immuno-oncology startup

August 17, 2016 Research and Development CD47, Cancer, GSK, Novo, Roche, Tioma, oncology

Brisbane-based venture-stage biopharmaceutical company Tioma Therapeutics has announced it has raised $86 million in Series A venture financing for its …
News
praluent_75mg_pen_box_hr

Amgen, Sanofi cholesterol medicines “not cost-effective”, need to drop price by two-thirds

August 17, 2016 Research and Development, Sales and Marketing Amgen, QALY, Regeneron, Repatha, Sanofi, cost effective, cost-effective, praluent

A new study published in JAMA has suggested that Amgen, Sanofi and Regeneron would have to reduce their prices for …
News
landing-hero-images1

ViiV Healthcare launches Phase III trial for combo HIV treatment

August 16, 2016 Research and Development Dolutegravir, HIV, Tivicay, ViiV Healthcare, epivir, lamivudine, phase III

The Pfizer/GSK spin off ViiV Healthcare has announced the beginning of a Phase III evaluating Tivicay (dolutegravir) and Epivir (lamivudine) …
News
msd

MSD to cut 148 jobs at Pennsylvania plant

August 16, 2016 Manufacturing and Production, Research and Development MSD, job cuts, zontivity

MSD is due to cut 148 jobs at its North Wales, Pennsylvania campus effective September 12, according to the company’s …
News

Ashfield launches Global Impact On Society Initiative

August 16, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Ashfield, part of UDG Healthcare plc (LON: UDG), a global leader in providing outsourced healthcare services to pharmaceutical, device and …
News
Press release

13 deaths in Aurinia’s lupus drug trial despite hitting Phase II target

August 16, 2016 Manufacturing and Production, Research and Development Aurinia, Phase II, biotech, patient deaths, voclosporin

Canadian biotech Aurinia Pharmaceuticals has announced the topline Phase IIb trial results of its lupus nephritis (LN) treatment voclosporin, which …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026